Veracyte VCYT Insider Ownership

NASDAQ VCYT

$45.82 +1.03 (+2.30%)

As of: Oct 21, 2026 · 1:01 PM EDT

Insider Holdings by Owner

1.60Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

1.71%

▼-0.067% pp QoQ

Shares Held by Insiders

1.37Mn

filed for Sep 2026

▼-3.80% QoQ

Shares Outstanding

80.36Mn

80,363,927 shares

Direct Holdings

1.37Mn

Indirect: 0

Net Shares Traded (QoQ)

-54.19K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Across the past 12 months, open-market trades by Veracyte insiders were all sales, totaling $21.03 million (472.35K shares).

Behind Veracyte's open-market sales in the past 12 months were 11 insiders, and no insider bought.
Marc Stapley (Chief Executive Officer) led open-market sales of Veracyte stock over the past 12 months with $8.92 million (191.24K shares), most recently on June 4, 2026.
The latest open-market trade in VCYT stock by an insider was a sale of 4.01K shares for $160,600 by John Leite (Global Chief Commercial Officer) on September 21, 2026.
In transactions other than open-market trades, Veracyte insiders received 668.08K shares in stock awards, acquired 212.05K shares through option exercises and conversions and gave up 213.53K shares to cover taxes or exercise prices over the past 12 months.
Business Quant data shows Veracyte insiders holding 1.37Mn shares in total in their latest Form 4 filings, or 1.71% of the 80.36Mn shares outstanding; that total is down 3.80% from 1.42Mn shares at the end of Q2 2026 and up 22.54% from 1.12Mn shares at the end of Q3 2025.
Veracyte insiders report no indirect holdings: all 1.37Mn shares are held directly.
Per Business Quant, 15 insiders of VCYT hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
Veracyte's three largest insider shareholders, based on their latest Form 4 filings, are Marc Stapley (Chief Executive Officer, 432.07K shares), Rebecca Chambers (Chief Financial Officer, 166.03K shares) and Phillip G. Febbo (Chief Scientific & Med Officer, 133.05K shares).
Marc Stapley holds 31.53% of the combined insider position in Veracyte.
A total of 66 Form 4 filings with transactions in Veracyte stock were made over the past 12 months, by 15 insiders.
These insider figures for Veracyte are based on Form 4 filings through September 22, 2026.

Form 4 Holdings

Insiders Holding VCYT

Insiders 20

Shares held 1.60Mn

Of outstanding 1.99%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Marc Stapley	Chief Executive Officer	432,073	432,073	27.1%	04 Sep, 2026
2	Rebecca Chambers	Chief Financial Officer	166,025	166,025	10.4%	04 Sep, 2026
3	Phillip G. Febbo	Chief Scientific Med Officer	133,048	133,048	8.3%	04 Sep, 2026
4	Annie Mcguire	Evp, General Counsel	131,160	131,160	8.2%	04 Sep, 2026
5	John Leite	Global Chief Commercial Off	124,329	124,329	7.8%	22 Sep, 2026
6	Tina Susan Nova	President, Clia U.S.	76,988	76,988	4.8%	07 Mar, 2022
7	Giulia C Kennedy	Chief Scientific Med Officer	65,970	65,970	4.1%	08 Dec, 2022
8	Robert S Epstein	Director	57,718	57,718	3.6%	15 Jun, 2026
9	Eliav Barr	Director	56,461	56,461	3.5%	15 Jun, 2026
10	Kevin Richard Haas	Chief Dev And Tech Officer	44,221	44,221	2.8%	14 Apr, 2026
11	Jonathan Wygant	Vp, Chief Accounting Officer	43,226	43,226	2.7%	04 Sep, 2026
12	Muna Bhanji	Director	42,718	42,718	2.7%	03 Sep, 2026
13	Bonnie H Anderson	Executive Chairwoman	41,377	41,377	2.6%	06 Jun, 2023
14	Evan/ Fa Jones	Director	34,634	34,634	2.2%	15 Jun, 2026
15	John L Bishop	Director	33,125	33,125	2.1%	19 Jul, 2023
16	Thomas F. Miller	Director	31,100	31,100	1.9%	15 Jun, 2026
17	David Brent Shafer	Director	31,100	31,100	1.9%	15 Jun, 2026
18	Jens Holstein	Director	27,471	27,471	1.7%	16 Sep, 2026
19	Karin Eastham	Director	15,097	15,097	0.9%	22 Jun, 2026
20	Kevin K Gordon	Director	8,720	8,720	0.5%	10 Jun, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,392 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
21 Sep, 2026	John Leite	Global Chief Commercial Off	Disposed S	4,015	$40.00	$160.60K	124,329	Direct
14 Sep, 2026	Jens Holstein	Director	Disposed S	5,000	$40.95	$204.75K	27,471	Direct
02 Sep, 2026	Marc Stapley	Chief Executive Officer	Disposed F	8,782	$44.88	$394.14K	432,073	Direct
02 Sep, 2026	Jonathan Wygant	Vp, Chief Accounting Officer	Disposed F	1,361	$44.88	$61.08K	43,226	Direct
02 Sep, 2026	Rebecca Chambers	Chief Financial Officer	Disposed F	3,603	$44.88	$161.70K	169,677	Direct
02 Sep, 2026	Annie Mcguire	Evp, General Counsel	Disposed F	3,215	$44.88	$144.29K	134,414	Direct
02 Sep, 2026	Phillip G. Febbo	Chief Scientific Med Officer	Disposed F	3,639	$44.88	$163.32K	146,158	Direct
02 Sep, 2026	John Leite	Global Chief Commercial Off	Disposed F	3,961	$44.88	$177.77K	128,344	Direct
04 Sep, 2026	Annie Mcguire	Evp, General Counsel	Disposed S	2,154	$42.79	$92.17K	132,260	Direct
04 Sep, 2026	Rebecca Chambers	Chief Financial Officer	Disposed S	2,477	$42.81	$106.03K	167,200	Direct
04 Sep, 2026	Phillip G. Febbo	Chief Scientific Med Officer	Disposed S	10,405	$42.89	$446.30K	135,753	Direct
04 Sep, 2026	Rebecca Chambers	Chief Financial Officer	Disposed S	1,175	$43.71	$51.36K	166,025	Direct
04 Sep, 2026	Phillip G. Febbo	Chief Scientific Med Officer	Disposed S	2,705	$43.66	$118.11K	133,048	Direct
04 Sep, 2026	Annie Mcguire	Evp, General Counsel	Disposed S	1,100	$43.67	$48.04K	131,160	Direct
01 Sep, 2026	Muna Bhanji	Director	Disposed S	1,864	$42.97	$80.10K	42,718	Direct
18 Jun, 2026	Karin Eastham	Director	Disposed S	3,200	$52.78	$168.91K	15,626	Direct
18 Jun, 2026	Karin Eastham	Director	Disposed S	529	$53.55	$28.33K	15,097	Direct
11 Jun, 2026	Jens Holstein	Director	Acquired A	5,272	$0.00	$0	32,471	Direct
11 Jun, 2026	Robert S Epstein	Director	Acquired A	5,272	$0.00	$0	57,718	Direct
11 Jun, 2026	Karin Eastham	Director	Acquired A	5,272	$0.00	$0	18,826	Direct

Showing 1 to 20 of 1,392 transactions